HDAC9 and neoplasm: Targeting HDACs holds significant potential for anti-tumor activity; HDAC inhibitors induce chromatin remodeling through increased levels of histone acetylation, rectifying epigenetic errors, promoting anti-tumor activity, and enhancing expression levels of tumor suppressor genes to inhibit cancer cell proliferation (40).